Paradigm Biopharmaceuticals Enters Voluntary Administration Following Phase 3 Trial Futility in September Quarter

Paradigm Biopharmaceuticals Ltd (ASX:PAR) PAR (ASX:PAR) announced that its Phase 3 knee osteoarthritis clinical trial met the pre-defined futility criterion at interim analysis, leading to the appointment of voluntary administrators effective 29 September 2026, as detailed in the company’s quarterly activities report for the period ending 30 September 2026. Key Points On 23 September 2026,…

NCLAT sets aside insolvency proceedings against Polycab over ₹2.78 crore dues

The dispute arose from supplies of aluminium ingots by Asier Metals. On October 7, the NCLT Ahmedabad admitted the operational creditor’s petition and appointed Sunit Jagdishchandra Shah as Interim Resolution Professional. Polycab had opposed the petition, arguing that the invoices reflected provisional billing, the parties’ ledgers required reconciliation and an ₹80 lakh deduction towards demurrage…

Polycab India Insolvency Proceedings Set Aside By NCLAT

Market snapshot: The National Company Law Appellate Tribunal has set aside corporate insolvency resolution proceedings initiated against Polycab India Limited. The earlier insolvency admission order by NCLT stemmed from a Section 9 petition regarding an alleged operational debt claim of ₹2.79 crore. Data Snapshot Alleged operational debt dispute under Section 9 IBC stands at ₹2.79…

No Cookies | The Cairns Post

To use this website, cookies must be enabled in your browser. To enable cookies, follow the instructions for your browser below. Facebook App: Open links in External Browser There is a specific issue with the Facebook in-app browser intermittently making requests to websites without cookies that had previously been set. This appears to be a…